Literature DB >> 17348809

A method for single-cell sorting and expansion of genetically modified human embryonic stem cells.

Cory R Nicholas1, Meenakshi Gaur, Shaohui Wang, Renee A Reijo Pera, Andrew D Leavitt.   

Abstract

Genetic modification of human embryonic stem (hES) cells is essential for studies of gene function and differentiation. The expression of transgenes may direct tissue-specific differentiation and aid in the identification of various differentiated cell types. Stable genomic integration of transgenes is optimal because hES cell differentiation can span several days to weeks and include numerous cell divisions, and establishing homogeneous modified cell lines will facilitate research studies. Herein we provide a method for producing and expanding hES cell lines from single cells that have been isolated by fluorescence-activated cell sorting (FACS) following genetic modification by lentivirus vectors. Using this method, we have established enhanced green fluorescent protein (eGFP)-expressing hES cell lines that are pluripotent, contain a diploid chromosomal content, and stably express eGFP following more than 2 months of routine culture and in vivo differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17348809     DOI: 10.1089/scd.2006.0059

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  12 in total

1.  Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.

Authors:  Yerem Yeghiazarians; Meenakshi Gaur; Yan Zhang; Richard E Sievers; Carissa Ritner; Megha Prasad; Andrew Boyle; Harold S Bernstein
Journal:  Cytotherapy       Date:  2011-10-31       Impact factor: 5.414

2.  Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes.

Authors:  Meenakshi Gaur; Carissa Ritner; Rich Sievers; Anissa Pedersen; Megha Prasad; Harold S Bernstein; Yerem Yeghiazarians
Journal:  Cytotherapy       Date:  2010-10       Impact factor: 5.414

Review 3.  Deconstructing human embryonic stem cell cultures: niche regulation of self-renewal and pluripotency.

Authors:  Morag H Stewart; Sean C Bendall; Mickie Bhatia
Journal:  J Mol Med (Berl)       Date:  2008-06-03       Impact factor: 4.599

4.  High-throughput tracking of pluripotent human embryonic stem cells with dual fluorescence resonance energy transfer molecular beacons.

Authors:  Frank W King; Walter Liszewski; Carissa Ritner; Harold S Bernstein
Journal:  Stem Cells Dev       Date:  2010-09-14       Impact factor: 3.272

Review 5.  Precision targeted therapy of ovarian cancer.

Authors:  Justin Sapiezynski; Oleh Taratula; Lorna Rodriguez-Rodriguez; Tamara Minko
Journal:  J Control Release       Date:  2016-10-14       Impact factor: 9.776

6.  Label-free separation of human embryonic stem cells and their differentiating progenies by phasor fluorescence lifetime microscopy.

Authors:  Chiara Stringari; Robert Sierra; Peter J Donovan; Enrico Gratton
Journal:  J Biomed Opt       Date:  2012-04       Impact factor: 3.170

7.  Ferromagnetic micropallets for magnetic capture of single adherent cells.

Authors:  Nicholas M Gunn; Ruth Chang; Trisha Westerhof; Guann-Pyng Li; Mark Bachman; Edward L Nelson
Journal:  Langmuir       Date:  2010-10-22       Impact factor: 3.882

Review 8.  Instructing an embryonic stem cell-derived oocyte fate: lessons from endogenous oogenesis.

Authors:  Cory R Nicholas; Shawn L Chavez; Valerie L Baker; Renee A Reijo Pera
Journal:  Endocr Rev       Date:  2009-04-14       Impact factor: 19.871

Review 9.  Single-Cell Analysis in Cancer Genomics.

Authors:  Assieh Saadatpour; Shujing Lai; Guoji Guo; Guo-Cheng Yuan
Journal:  Trends Genet       Date:  2015-10       Impact factor: 11.639

10.  Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures.

Authors:  Frank W King; Carissa Ritner; Walter Liszewski; Helen C K Kwan; Anissa Pedersen; Andrew D Leavitt; Harold S Bernstein
Journal:  Stem Cells Dev       Date:  2009-12       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.